Mackenzie Financial Corp Harvard Bioscience Inc Transaction History

Mackenzie Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$3.28 - $6.42 $34,558 - $67,641	-10,536 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $738 - $948	-116 Reduced 1.09%	10,536 $74,000
Q3 2021 Nov 08, 2021	BUY	$6.98 - $8.47 $74,350 - $90,222	10,652 New	10,652 $74,000
Q2 2021 Aug 11, 2021	SELL	$5.44 - $8.4 $54,400 - $84,000	-10,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$3.91 - $6.99 $21,896 - $39,144	-5,600 Reduced 35.9%	10,000 $55,000
Q3 2020 Nov 13, 2020	BUY	$2.75 - $4.2 $42,900 - $65,520	15,600 New	15,600 $47,000

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.